Email:
[email protected]
Login
Register
English
Deutsch
Español
Français
Português
Home
Add new document
Sign In
Create An Account
Clinical Indicators and Preventive Care
HOME
Clinical Indicators and Preventive Care
Clinical Indicators and Preventive Care
Dialysis adequacy 100% (KDOQI target) 100% (KDOQI target) Vascular access 100% (KDOQI target) 50% (KDOQI target) Anemia mgmt Diabetic care Vacc...
Download PDF
5MB Sizes
0 Downloads
83 Views
Report
Recommend Documents
Chapter 3: Clinical Indicators and Preventive Care
Chapter 3: Clinical Indicators and Preventive Care
Clinical Indicators & Preventive Health
4. Clinical indicators of care
Clinical and Community Delivery Systems for Preventive Care
Preventive care
Clinical Preventive Medicine in Primary Care: Background and Practice: 3. Delivering Preventive Screening Services
Culture and Preventive Health Care
Preventive health care
Measuring Preventive Care Delivery
Selecting Clinical Outcome Indicators for Monitoring Quality of Care
Accessibility and the demand for preventive care
Full Text
Dialysis adequacy 100% (KDOQI target)
100% (KDOQI target)
Vascular access 100% (KDOQI target)
50% (KDOQI target)
Anemia mgmt
Diabetic care
Vaccinations
90%
90%
90%
90% (HP2020 target)
18.8% (2009)
51.8% (2009)
58.1% (2009)
17% (2009)
64.3% (2009)
Pts w/hb >12 g/dl
DM pts w/4+ A1c tests
DM pts w/2+ lipid tests
DM pts w/ comp. DM mon.
ESRD pts w/ 1 flu vaccin.
55.0% (2008) 50% (KDOQI target)
93.4% (2008)
94% (2009)
87.1% (2009)
30.8% (2008)
HD pts with delivered Kt/V ≥1.2
HD pts w/ URR ≥65%
CAPD pts with delivered Kt/V ≥1.7
New pts w/AV fistula as first access
77.2% (2009) Prev. pts w/ AVF as current access
Pts w/hb 10-12 g/dl
4.1% (2009) Pts w/hb <10 g/dl
25.8% (20082009) ESRD pts w/1 pneumonia vaccin.
22.1% (2009) ESRD pts w/1 hep B vaccin.
13+ Hemoglobin (g/dl)
>12-<13
60 40 9-<10 <9
20
Hemoglobin EPO
11
15
10
10
10-<11
0 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09
Hemoglobin (g/dl)
13 2005 2001
12
2009
11
1997 10 9 8 1
2
3
4
5
6
Mean wkly EPO dose (1,000s of units)
9 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09
5
30 25 2009
2005
20 2001
15
1997
10 5 1
2
3
4
5
6
Months after initiation
Months after initiation
50
50 6 months
40 30
4-<6
20 10
2-<4
Percent of patients
20
11-12
Percent of patients
Percent of patients
80
12
Mean weekly EPO dose (1,000s of units)
100
40 30
2,700+ 1,200-<2,100 2,100-<2,700
20 0-<1,200 mg 10
0-<2 0
0 00 01 02 03 04 05 06 07 08 09
00 01 02 03 04 05 06 07 08 09
100
100
80 60 40 20
3 tests 2 tests 1 test
4+ tests Percent of patients
Percent of patients
4+ tests 80
3 tests 60 2 tests 40 1 test 20
% with comprehensive monitoring
No tests
No tests
0
0
96-97 98-99 00-01 02-03 04-05 06-07 08-09
96-97 98-99 00-01 02-03 04-05 06-07 08-09
20
15
10
5
0 96-97 98-99 00-01 02-03 04-05 06-07 08-09
80
Percent of patients
Catheter
60 AV fistula Catheter w/maturing fistula
40
AV graft Catheter w/maturing graft
20
0 2005
2006
2007
2008
2009
80
Dialysis All White African American Asian Other Hispanic
60
Percent of patients
40
20
0 80
Transplant
60
40
20
0 A
B
C
D
E
F
G
H
I
Percent of patients
60
Dialysis
Transplant All White African American Asian Other Hispanic
40
20
0 A
C
D
E
F
Dialysis
A
B
C
D
E
F
Transplant
100
All White African American Asian Other Hispanic
10
5
Percent of patients
Percent of patients
15
B
0
Percent of patients
80
Dialysis
Calcitriol Paricalcitol Inactivated Doxercalciferol vitamin D
Transplant All White African American Asian Other Hispanic
60 40 20 0 A
B
C
D
E
F
G
A
B
C
D
E
F
G
Asian Other Hispanic
60 40 20 0
Calcitriol Paricalcitol Inactivated Doxercalciferol vitamin D
All White Af Am
80
Any
Sev- Calcium Lanth- Comb. ≥1 elemer acetate anum month
×
Report "Clinical Indicators and Preventive Care"
Your name
Email
Reason
-Select Reason-
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Description
Our partners will collect data and use cookies for ad personalization and measurement.
Learn how we and our ad partner Google, collect and use data
.
Agree & close